ArticleFrontiers in oncology2022

The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization.

Tzu-Ping Chien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.